TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28776431

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavior therapy with therapist support (n=20)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Internet-based cognitive-behavior therapy without therapist support (n=22)
Number of subjects: 42
Study: 27838685

Group type: EXPERIMENTAL
Intervention: Personalized, spectrally altered classical music therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Unaltered classical music (Control)
Number of subjects: 50
Study: 24390009

Group type: EXPERIMENTAL
Intervention: Low-intensity pulsed ultrasound (LIPUS) for 20 minutes daily during treatment
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group without LIPUS treatment
Number of subjects: 21
Study: 22646847

Group type: EXPERIMENTAL
Intervention: Olanzapine long-acting injection (405 mg/4 weeks, 210 or 300 mg/2 weeks)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Oral olanzapine (10 ± 2.5 or 15 ± 2.5 mg/day)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Haloperidol (15 ± 5 mg/day)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Olanzapine LAI
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Oral olanzapine
Number of subjects: 404

Group type: COMPARATOR
Intervention: Haloperidol and placebo
Number of subjects: 404

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 404
Study: 19387396

Group type: EXPERIMENTAL
Intervention: HMB supplementation (3 g/d)
Number of subjects: 22
Study: 18088023

Group type: EXPERIMENTAL
Intervention: Active sublingual immunotherapy with SLITone grass mix plus olive pollen extract for 6 months
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 15148271

Group type: EXPERIMENTAL
Intervention: Leukocyte-depleted erythrocytes (LD)
Number of subjects: 496

Group type: COMPARATOR
Intervention: Standard buffy coat-depleted erythrocytes (PC)
Number of subjects: 496
Study: 11575872

Group type: EXPERIMENTAL
Intervention: LongoVital (LV)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 10872623

Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic lobectomy (VATS), n = 22 patients
Number of subjects: 44

Group type: COMPARATOR
Intervention: Thoracotomy approach, n = 22 patients
Number of subjects: 44
Study: 8584467

Group type: EXPERIMENTAL
Intervention: Intensive, specific exercise using firm pelvic stabilization to isolate and rehabilitate the lumbar spine musculature.
Number of subjects: 895

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 895
Study: 2802032

Group type: EXPERIMENTAL
Intervention: Hemiglossectomy and radical neck dissection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hemiglossectomy alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tumor depth < 4 mm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tumor depth > 4 mm
Number of subjects: 0
Study: 60633

Group type: EXPERIMENTAL
Intervention: Training programme for history-taking skills
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Discussion of a printed handout presenting a detailed scheme for taking histories
Number of subjects: 0
Study: 31759804

Group type: EXPERIMENTAL
Intervention: FRESH behavioral intervention (2 home visits and 7 phone sessions)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: FRESH behavioral intervention
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 300
Study: 31324206

Group type: EXPERIMENTAL
Intervention: Oral tinidazole
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Penile topical metronidazole
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Topical clindamycin
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Topical hydrogen peroxide
Number of subjects: 125

Group type: COMPARATOR
Intervention: Immediate penile circumcision (control)
Number of subjects: 125
Study: 28525569

Group type: COMPARATOR
Intervention: Methylphenidate
Number of subjects: 21

Group type: COMPARATOR
Intervention: Modafinil
Number of subjects: 21

Group type: COMPARATOR
Intervention: 3,4‐methylenedioxymethamphetamine
Number of subjects: 21
Study: 25950723

Group type: EXPERIMENTAL
Intervention: EPAP nasal strip
Number of subjects: 219
Study: 23988600

Group type: EXPERIMENTAL
Intervention: Enhanced intervention
Number of subjects: 732

Group type: EXPERIMENTAL
Intervention: Minimal intervention
Number of subjects: 732

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 732
Study: 19850570

Group type: EXPERIMENTAL
Intervention: High-intensity intervention (group A)
Number of subjects: 1308

Group type: COMPARATOR
Intervention: Usual care (group B)
Number of subjects: 1308

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 1308
Study: 19909586

Group type: EXPERIMENTAL
Intervention: Single-dose GnRH agonist (0.5 mg leuprolide acetate) administered subcutaneously on day 6 after ICSI
Number of subjects: 164

Group type: COMPARATOR
Intervention: Standard luteal support (intravaginal 600 mg micronized progesterone) without GnRH agonist
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Single-dose GnRH agonist
Number of subjects: 164

Group type: COMPARATOR
Intervention: Standard luteal support
Number of subjects: 164
Study: 16736388

Group type: EXPERIMENTAL
Intervention: Venlafaxine extended release (VXR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional antidepressants (CA, mainly SSRIs)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional antidepressants (CA)
Number of subjects: 120
Study: 16035398

Group type: EXPERIMENTAL
Intervention: Nimesulide (200 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ibuprofen (1200 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nimesulide and Ibuprofen (both)
Number of subjects: 0
Study: 11384793

Group type: COMPARATOR
Intervention: Placebo diet intervention, no house dust mite reduction (Group A)
Number of subjects: 616

Group type: COMPARATOR
Intervention: Placebo diet intervention, active house dust mite reduction (Group B)
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: Active diet intervention, no house dust mite reduction (Group C)
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: Active diet intervention, active house dust mite reduction (Group D)
Number of subjects: 616
Study: 9422014

Group type: EXPERIMENTAL
Intervention: Partially randomised patient preference design
Number of subjects: 273

Group type: COMPARATOR
Intervention: Conventional randomised controlled design
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Medical management
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Transcervical resection of the endometrium
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Transcervical resection of the endometrium (chosen or randomised)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Medical management (chosen)
Number of subjects: 273
Study: 8426038

Group type: EXPERIMENTAL
Intervention: Social service intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 3391053

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (Rocephin)/gentamicin
Number of subjects: 49

Group type: COMPARATOR
Intervention: Azlocillin/gentamicin
Number of subjects: 49
Study: 30753672

Group type: EXPERIMENTAL
Intervention: Dietary weight loss (8-week intervention)
Number of subjects: 77
Study: 28116801

Group type: EXPERIMENTAL
Intervention: oral ezetimibe 10 mg daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 50
Study: 25957549

Group type: EXPERIMENTAL
Intervention: Tendisulfur(®) (group T)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (group P)
Number of subjects: 0
Study: 23994369

Group type: EXPERIMENTAL
Intervention: 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) at 500 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Allopurinol at 500 mg/kg
Number of subjects: 0
Study: 21489570

Group type: EXPERIMENTAL
Intervention: Almonds (28 g) consumed with a standardized meal
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Chronic almond ingestion (1 serving 5 d/wk for 12 weeks)
Number of subjects: 19
Study: 19670137

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (GTN)
Number of subjects: 1920

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1920
Study: 21333560

Group type: EXPERIMENTAL
Intervention: Endovenous laser ablation (EVLA) without saphenofemoral junction ligation (SFL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Endovenous laser ablation (EVLA) with saphenofemoral junction ligation (SFL)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Endovenous laser ablation (EVLA) without SFL
Number of subjects: 30

Group type: COMPARATOR
Intervention: Endovenous laser ablation (EVLA) with SFL
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 15716167

Group type: COMPARATOR
Intervention: NoGo-P3 latency in PD group
Number of subjects: 13

Group type: COMPARATOR
Intervention: NoGo-P3 amplitude in PD group
Number of subjects: 13

Group type: COMPARATOR
Intervention: NoGo-N2 amplitude in PD group
Number of subjects: 13

Group type: COMPARATOR
Intervention: Omission and commission errors during ERP task in PD group
Number of subjects: 13

Group type: COMPARATOR
Intervention: Cognitive function tests (WCST and VFT) in PD group
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: NoGo-P3 latency correlation
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: NoGo-P3 amplitude correlation
Number of subjects: 13
Study: 11793403

Group type: EXPERIMENTAL
Intervention: 50 Hz electric and magnetic field at 100 V/m and 6 microT (EMF sensitive)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Sham exposure (field off)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Exposed (field on)
Number of subjects: 63
Study: 9721057

Group type: EXPERIMENTAL
Intervention: Dropped posture (DP)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Upright posture (UP)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Aero posture (AP)
Number of subjects: 9
Study: 7648909

Group type: EXPERIMENTAL
Intervention: Capillary blood glucose test
Number of subjects: 220
Study: 2667606

Group type: EXPERIMENTAL
Intervention: Vigabatrin (GVG)
Number of subjects: 89
Study: 405624

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 47

Group type: COMPARATOR
Intervention: Phenytoin
Number of subjects: 47
Study: 11768838

Group type: EXPERIMENTAL
Intervention: Almotriptan 6 mg
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Almotriptan 10 mg
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Almotriptan 2 mg
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 29688615

Group type: EXPERIMENTAL
Intervention: Bococizumab 150 mg subcutaneous injection via prefilled syringe (PFS) using drug substance manufactured by Pfizer
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Bococizumab 150 mg subcutaneous injection via prefilled syringe (PFS) using drug substance manufactured by Boehringer Ingelheim Pharma
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Bococizumab 150 mg subcutaneous injection via prefilled pen using drug substance manufactured by Pfizer
Number of subjects: 157

Group type: COMPARATOR
Intervention: All treatments (PFS by Pfizer, PFS by Boehringer Ingelheim, prefilled pen by Pfizer)
Number of subjects: 157
Study: 29449189

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy (radiotherapy plus chemotherapy consisting of two cycles of cisplatin 50 mg/m2 during radiotherapy, followed by four cycles of carboplatin AUC5 and paclitaxel 175 mg/m2)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Radiotherapy alone (48.6 Gy in 1.8 Gy fractions given on 5 days per week)
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy
Number of subjects: 660

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 660
Study: 25808454

Group type: EXPERIMENTAL
Intervention: Dopamine
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 94
Study: 24220749

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg administered 1 h preoperatively
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo 200 mg administered 1 h preoperatively
Number of subjects: 53
Study: 23023808

Group type: EXPERIMENTAL
Intervention: Harmonic Focus group
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study: 21162930

Group type: EXPERIMENTAL
Intervention: Patients with Hirayama disease
Number of subjects: 123

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 123
Study: 17434845

Group type: EXPERIMENTAL
Intervention: FOTO treatment schedule (5 days on, 2 days off)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: FOTO treatment schedule with efavirenz-based regimens
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: FOTO treatment schedule
Number of subjects: 30
Study: 15154088

Group type: EXPERIMENTAL
Intervention: FSH treatment (n=24)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (non-treated, n=20)
Number of subjects: 44
Study: 12243815

Group type: EXPERIMENTAL
Intervention: 5‐fluorouracil (5‐FU) by protracted venous infusion
Number of subjects: 656

Group type: COMPARATOR
Intervention: 5‐fluorouracil (5‐FU) by bolus
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: Anterior resection
Number of subjects: 656

Group type: COMPARATOR
Intervention: Abdominoperineal resection
Number of subjects: 656
Study: 7808895

Group type: EXPERIMENTAL
Intervention: Thermal perception scale (TS) during exposure to cold air at 8 degrees, 12 degrees, and 27 degrees C for 120 min.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Thermal perception scale (TS)
Number of subjects: 8
Study: 2803403

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo or four inhalant anti-asthmatic drugs
Number of subjects: 13
Study: 1125119

Group type: EXPERIMENTAL
Intervention: QX-572 (8 mg/kg body weight intravenously over 30 minutes)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: QX-572
Number of subjects: 67
Study: 30906714

Group type: EXPERIMENTAL
Intervention: Titanium partial ossicular replacement prosthesis (PORP)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Titanium total ossicular replacement prosthesis (TORP)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Autologous cartilage short columella ossiculoplasty (SCC)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Autologous cartilage long columella ossiculoplasty (LCC)
Number of subjects: 32
Study: 28051877

Group type: EXPERIMENTAL
Intervention: Adventures aboard the S.S. GRIN (computer-based game)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 69
Study: 26304941

Group type: EXPERIMENTAL
Intervention: Colchicine (1 mg followed by 0.5 mg 1 hour later)
Number of subjects: 83

Group type: COMPARATOR
Intervention: No colchicine (control)
Number of subjects: 83
Study: 23538664

Group type: EXPERIMENTAL
Intervention: 0.5 gram monosodium glutamate (MSG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.5 gram iodized salt
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both interventions (MSG and iodized salt)
Number of subjects: 60
Study: 20951830

Group type: EXPERIMENTAL
Intervention: Natural flour baked goods (NFBG) (80,127 ppm gluten; n = 6)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Extensively hydrolyzed flour baked goods (S1BG) (2480 ppm residual gluten; n = 2)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Fully hydrolyzed baked goods (S2BG) (8 ppm residual gluten; n = 5)
Number of subjects: 13
Study: 18449849

Group type: EXPERIMENTAL
Intervention: EPs 7630
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study: 16571156

Group type: EXPERIMENTAL
Intervention: Multi-vitamin/mineral (MVM) and zinc (Zn) supplementation
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Multi-vitamin/mineral (MVM)
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Zinc (Zn)
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Multi-vitamin/mineral (MVM) and zinc (Zn) combined
Number of subjects: 499

Group type: COMPARATOR
Intervention: Placebo (for both MVM and Zn)
Number of subjects: 499
Study: 12421053

Group type: EXPERIMENTAL
Intervention: Visual identity primes (silent reading or semantic processing)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Auditory identity primes (generating an associate or a rhyme)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonwords
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-frequency words presented in the lexical decision task
Number of subjects: 0
Study: 10341163

Group type: EXPERIMENTAL
Intervention: D-tagatose (29 g)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sucrose (29 g)
Number of subjects: 29
Study: 7627294

Group type: EXPERIMENTAL
Intervention: No-rinse cleanser with moisture barrier
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: No-rinse cleanser without moisture barrier
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Soap and water with moisture barrier
Number of subjects: 10

Group type: COMPARATOR
Intervention: Soap and water without moisture barrier
Number of subjects: 10
Study: 2390547

Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 146

Group type: COMPARATOR
Intervention: Regional anaesthesia
Number of subjects: 146
Study: 6793298

Group type: EXPERIMENTAL
Intervention: 0.5mg NET + 35 microgram EE
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Products containing EDA and NET
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: LNG‐containing preparation
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: NET or EDA preparations
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: LNG preparation
Number of subjects: 4
Study: 30855417

Group type: EXPERIMENTAL
Intervention: Histogram analysis of gray-scale ultrasound images in CHB patients
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Subgroups of CHB patients according to HAI stage
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: First percentile values in CHB patients
Number of subjects: 52
Study: 29674252

Group type: EXPERIMENTAL
Intervention: Travel assistance (16.0%)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Distance from study site
Number of subjects: 119

Group type: COMPARATOR
Intervention: Marital status of primary caregiver
Number of subjects: 119

Group type: COMPARATOR
Intervention: Socioeconomic status (SES) variables
Number of subjects: 119
Study: 28683560

Group type: EXPERIMENTAL
Intervention: 16-week dance intervention (BAILAMOS)
Number of subjects: 21

Group type: COMPARATOR
Intervention: wait-list control
Number of subjects: 21
Study: 26316098

Group type: EXPERIMENTAL
Intervention: Needle-guided technique
Number of subjects: 160

Group type: COMPARATOR
Intervention: Freehand technique
Number of subjects: 160
Study: 23945981

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 75
Study: 20336327

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) during intravenous chemotherapy
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control group (no VR during intravenous chemotherapy)
Number of subjects: 137
Study: 18292082

Group type: EXPERIMENTAL
Intervention: 4% amethocaine gel (AnGEL)
Number of subjects: 177

Group type: COMPARATOR
Intervention: 5% lidocaine and prilocaine in a 1:1 emulsion (EMLA)
Number of subjects: 177
Study: 16542370

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg daily for 14 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study: 12669261

Group type: EXPERIMENTAL
Intervention: Simulated 30-min individual time-trial (ITT30) at self-selected intensity
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Self-selected intensity during ITT30
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ITT30 performance test
Number of subjects: 12
Study: 10634372

Group type: EXPERIMENTAL
Intervention: Orbital radiotherapy (telecobalt) in 20 fractions of 1 Gray (Gy) weekly over 20 weeks (group A)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Orbital radiotherapy (telecobalt) in 10 fractions of 1 Gy daily over 2 weeks (group B)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Orbital radiotherapy (telecobalt) in 10 fractions of 2 Gy daily over 2 weeks (group C)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Comparison of group A vs. group C
Number of subjects: 36

Group type: COMPARATOR
Intervention: Comparison of group A vs. group B
Number of subjects: 36

Group type: COMPARATOR
Intervention: Comparison of group B vs. group C
Number of subjects: 36
Study: 9150778

Group type: EXPERIMENTAL
Intervention: isoflurane-nitrous oxide-oxygen
Number of subjects: 12

Group type: COMPARATOR
Intervention: isoflurane-air-oxygen
Number of subjects: 12
Study: 7960186

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment preceding gamete recovery
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Presence of peroxidase-positive cells (> 6 x 10(6)/ml)
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Presence of microorganisms in semen
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Increased presence of peroxidase-negative cells
Number of subjects: 391
Study: 3296741

Group type: EXPERIMENTAL
Intervention: Metolazone-furosemide combination
Number of subjects: 9

Group type: COMPARATOR
Intervention: Thiazide-furosemide combination
Number of subjects: 9
Study: 29089415

Group type: EXPERIMENTAL
Intervention: Periprocedural heparin (HEP+)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: TICI 2b-3 reperfusion
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Stent retriever use
Number of subjects: 173

Group type: COMPARATOR
Intervention: Intubation
Number of subjects: 173

Group type: COMPARATOR
Intervention: Diabetes
Number of subjects: 173

Group type: COMPARATOR
Intervention: NIHSS
Number of subjects: 173

Group type: COMPARATOR
Intervention: Time from symptom onset to puncture
Number of subjects: 173

Group type: COMPARATOR
Intervention: Heart failure
Number of subjects: 173
Study: 25968885

Group type: EXPERIMENTAL
Intervention: On-pump CABG
Number of subjects: 615

Group type: COMPARATOR
Intervention: Off-pump CABG
Number of subjects: 615
Study: 26281144

Group type: EXPERIMENTAL
Intervention: Bortezomib intervention for late ABMR
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: DSA+ABMR+ patients
Number of subjects: 714
Study: 23493382

Group type: EXPERIMENTAL
Intervention: Systolic BP visit‐to‐visit variability (SBV)
Number of subjects: 908